Literature DB >> 8915471

Cancer and comorbidity in older patients: a descriptive profile.

R Yancik1, R J Havlik, M N Wesley, L Ries, S Long, W K Rossi, B K Edwards.   

Abstract

In 1992, the National Institute on Aging (NIA) and the National Cancer Institute (NCI) initiated a study to assess the prevalence of comorbid conditions in elderly patients with cancer. Seven cancer sites were selected for the study: breast, cervix, ovary, prostate, colon, stomach, and urinary bladder. This report on approximately 7600 patients in the study sample describes the NIA/NCI approach to developing information on comorbidity in elderly patients and addresses the chronic disease burden (i.e., comorbidity) and severity for six particular conditions: arthritis, chronic obstructive pulmonary disease (COPD), diabetes, gastrointestinal problems, heart-related conditions, and hypertension. Data on comorbidity were collected by abstracting information from hospital medical records. Patients were registered in six geographic areas of the NCI Surveillance, Epidemiology, and End Results (SEER) Program. A stratified random sample of patients aged 55 to 64, 65 to 74, and 75 years or older-with the index cancers were selected. Comorbidity data were matched with data from the conventional SEER monitoring system. Analyses showed that hypertension is the most prevalent condition and is also much more common as a current management problem rather than as history for the NIA/NCI SEER Study patients. Heart conditions varied slightly in the percentage of severity reported, but percentages for all tumors remained within a range of 13 to 26% for current and past categories. A similar range was observed for arthritis, with the higher percentage seen in the current problem category. For episodic complaints (e.g., gastrointestinal problems), a medical history was more common, except for cancers that involve complaints associated with the malignancy (e.g., colon and stomach cancers and, to a lesser extent, ovarian cancer). COPD and diabetes were less prevalent. Analyses currently under way will determine the impact of a patient's comorbidity burden on the cancer care continuum of diagnosis, treatment, and survival. The broad and independent effects of chronic conditions, singly and in combination, are being examined.

Entities:  

Mesh:

Year:  1996        PMID: 8915471     DOI: 10.1016/s1047-2797(96)00063-4

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  49 in total

1.  Longitudinal patterns in survival, comorbidity, healthcare utilization and quality of care among older women following breast cancer diagnosis.

Authors:  Amresh D Hanchate; Kerri M Clough-Gorr; Arlene S Ash; Soe Soe Thwin; Rebecca A Silliman
Journal:  J Gen Intern Med       Date:  2010-06-08       Impact factor: 5.128

Review 2.  [Chemotherapy in the elderly].

Authors:  G Lümmen; H Rübben
Journal:  Urologe A       Date:  2003-11       Impact factor: 0.639

Review 3.  [Oncologic pharmacotherapy of elderly patients].

Authors:  U Wedding; U Merkel; K Farker; K Höffken
Journal:  Internist (Berl)       Date:  2003-08       Impact factor: 0.743

Review 4.  Comorbidity in patients with cancer of the head and neck: prevalence and impact on treatment and prognosis.

Authors:  Jay F Piccirillo; Anna Vlahiotis
Journal:  Curr Oncol Rep       Date:  2006-03       Impact factor: 5.075

5.  Patient and physician views on providing cancer patient-specific survival information.

Authors:  Nancy L Solowski; Oluwafunmilola T Okuyemi; Dorina Kallogjeri; Joyce Nicklaus; Jay F Piccirillo
Journal:  Laryngoscope       Date:  2013-12-11       Impact factor: 3.325

6.  Impact of age-related comorbidity on results of colorectal cancer surgery.

Authors:  Corrado Pedrazzani; Guido Cerullo; Giovanni De Marco; Daniele Marrelli; Alessandro Neri; Alfonso De Stefano; Enrico Pinto; Franco Roviello
Journal:  World J Gastroenterol       Date:  2009-12-07       Impact factor: 5.742

Review 7.  Bladder cancer in the elderly.

Authors:  Shahrokh F Shariat; Matthew Milowsky; Michael J Droller
Journal:  Urol Oncol       Date:  2009 Nov-Dec       Impact factor: 3.498

8.  Incident comorbidities and all-cause mortality among 5-year survivors of Stage I and II breast cancer diagnosed at age 65 or older: a prospective-matched cohort study.

Authors:  Jennifer H Jordan; Soe Soe Thwin; Timothy L Lash; Diana S M Buist; Terry S Field; Reina Haque; Pamala A Pawloski; Hans V Petersen; Marianne N Prout; Virginia P Quinn; Marianne Ulcickas Yood; Rebecca A Silliman; Ann M Geiger
Journal:  Breast Cancer Res Treat       Date:  2014-06-18       Impact factor: 4.872

9.  [Geriatric assessment. Is it significantly helpful in selection of elderly tumour patients for a difficult therapy?].

Authors:  S Krege; C Friedrich; G Lümmen; L Pientka; H Rübben
Journal:  Urologe A       Date:  2004-08       Impact factor: 0.639

10.  Aging in the context of cancer prevention and control : perspectives from behavioral medicine.

Authors:  Keith M Bellizzi; Karen M Mustian; Deborah J Bowen; Barbara Resnick; Suzanne M Miller
Journal:  Cancer       Date:  2008-12-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.